Priya Rastogi News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Priya rastogi. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Priya Rastogi Today - Breaking & Trending Today

GW Hospital sued for negligence before former patient's death

GW Hospital sued for negligence before former patient's death
gwhatchet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from gwhatchet.com Daily Mail and Mail on Sunday newspapers.

Keith Mortman , Jon Stefanuca , Priya Rastogi , H Briggs Bedigian , Robert Laureno , Elizabeth Molony Allen , Patrick Tate , Georgetown University School Of Medicine , Gw Medical Faculty Associates , Dc Superior Court , Medstar Health , Spokespersons For The University , Medstar Washington Hospital Center , Medstar Georgetown Medical Center , Faculty Associates , Court Monday , Georgetown University School , Medstar Washington Hospital , கேய்ட் மோர்ட்மேன் , பிரியா ரஸ்டோகி , பேட்ரிக் டேட் , ஜார்ஜ்டவுன் பல்கலைக்கழகம் பள்ளி ஆஃப் மருந்து , க்வ் மருத்துவ ஆசிரிய கூட்டாளிகள் , டச் உயர்ந்தது நீதிமன்றம் , மெட்ஸ்டார் ஆரோக்கியம் , மெட்ஸ்டார் வாஷிங்டன் மருத்துவமனை மையம் ,

More Support for Gene Assay to Guide Breast Cancer Treatment

email article
Patients with ultralow-risk breast cancer according to genomic assessment had excellent long-term outcomes regardless of clinical risk or whether they received adjuvant therapy, a new analysis of a randomized trial showed.
The 8-year breast cancer-specific survival (BCSS) was 99.2% among patients classified as clinically high-risk but ultralow-risk by the MammaPrint 70-gene assay. Patients with an ultralow-risk genomic assessment and low clinical risk had an 8-year BCSS of 99.7%. Freedom from distant metastasis at 8 years was 97.6% in patients who were clinically and genomically low-risk versus 95.0% for those who were clinically high-risk but genomically low-risk.
In patients with an ultralow-risk genomic assessment, the 8-year distant metastasis-free interval (DMFI) rate was 97.8% with no adjuvant systemic therapy. That compared with an 8-year DMFI of 97.4% in patients who received only adjuvant endocrine therapy and 94.9% in patients who received ....

United States , Noord Holland , Priya Rastogi , Charles Bankhead , Josephine Lopes Cardozo , National Surgical Adjuvant Breast , American Society Of Clinical Oncology , University Of Pittsburgh , Netherlands Cancer Institute , American Society , Clinical Oncology , Surgical Adjuvant Breast , Bowel Project , Medpage Today , Endocrine Therapy , Breast Cancer , ஒன்றுபட்டது மாநிலங்களில் , நூற்த் ஹாலண்ட் , பிரியா ரஸ்டோகி , சார்லஸ் வங்கித் தலை , ஜோசபின் லோப்ஸ் கார்டோசோ , அமெரிக்கன் சமூகம் ஆஃப் மருத்துவ புற்றுநோயியல் , பல்கலைக்கழகம் ஆஃப் பிட்ஸ்பர்க் , நெதர்லாந்து புற்றுநோய் நிறுவனம் , அமெரிக்கன் சமூகம் , மருத்துவ புற்றுநோயியல் ,

Less Treatment May Be Fine for Some Women With Breast Cancer

December 10, 2020
Postmenopausal women may be able to skip some treatments, thereby avoiding some debilitating side effects, new research says.
Roy James Shakespeare/Getty Images
It may be possible for some postmenopausal women to avoid some breast cancer treatment without compromising survival, according to two new studies presented at the San Antonio Breast Cancer Symposium (SABCS), hosted by UT Health San Antonio, the American Association for Cancer Research, and the Dan L. Duncan Comprehensive Cancer Center at Baylor College of Medicine.
The meeting was held virtually December 8 to 11.
One study found that postmenopausal women with early-stage breast cancer who were at low risk of recurrence can skip chemotherapy after surgery. The other found that older patients may be able to skip radiation therapy following breast-conserving surgery. ....

Ann Arbor , United States , United Kingdom , San Antonio , Baylor College Of Medicine , University Of Texas , City Of , Kevin Kalinsky , Priya Rastogi , C Kent Osborne , Reshma Jagsi , Ian Kunkler , National Surgical Adjuvant Breast , University Of Edinburgh , University Of Michigan , American Association For Cancer Research , University Of Pittsburgh , Cancer Research Network , Ut Health San Antonio , Sciences In Medicine , University Of Texas Health Sciences Center , San Antonio Breast Cancer Symposium , American Association , Cancer Research , Comprehensive Cancer Center , Baylor College ,

monarchE: Abemaciclib Reigns on in High-Risk Breast Cancer

monarchE: Abemaciclib Reigns on in High-Risk Breast Cancer
medscape.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medscape.com Daily Mail and Mail on Sunday newspapers.

Palo Alto , United States , Stanford University , San Antonio , Priya Rastogi , C Kent Osborne , Carlosl Arteaga , Ut Southwestern Medical Center , Stanford University Medical Center , Ut Health San Antonio Cancer Center , University Of Pittsburgh Department Medicine , Breast Cancer Program , Virtual Congress , Simmons Comprehensive Cancer Center , Antonio Breast Cancer Symposium , Medscape Medical News , Pittsburgh Department , Duncan Cancer Center , Baylor College , Virginia Kaklamani , San Antonio Cancer Center , Medical Center , பாலோ ஆல்டோ , ஒன்றுபட்டது மாநிலங்களில் , ஸ்டான்போர்ட் பல்கலைக்கழகம் , சான் அன்டோனியோ ,

New data shows abemaciclib continues to benefit high-risk, HR+, HER2-, early-stage breast cancer patients

Extended follow-up data from the phase III monarchE trial showed that adding the cyclin-dependent kinase (CDK) inhibitor abemaciclib (Verzenio) to standard adjuvant endocrine therapy continued to improve invasive disease-free survival (IDFS) among patients with high-risk, node-positive, early-stage, HR-positive, HER2-negative breast cancer, according to data presented at the 2020 San Antonio Breast Cancer Symposium, held Dec. 8-11. ....

San Antonio , United States , Priya Rastogi , Emily Henderson , National Surgical Adjuvant Breast , University Of Pittsburgh Department Medicine , Antonio Breast Cancer Symposium , Pittsburgh Department , Bowel Project , சான் அன்டோனியோ , ஒன்றுபட்டது மாநிலங்களில் , பிரியா ரஸ்டோகி , எமிலி ஹென்டர்சன் , பல்கலைக்கழகம் ஆஃப் பிட்ஸ்பர்க் துறை மருந்து , அன்டோனியோ மார்பக புற்றுநோய் சிம்போசியம் , பிட்ஸ்பர்க் துறை , குடல் ப்ராஜெக்ட் ,